New Federal Fraud Initiative Raises Risks for Healthcare Companies
What's happening
Healthcare and life sciences companies are being warned that a new federal civil-rights and fraud enforcement initiative could increase legal exposure across the industry.
The initiative focuses on situations where organizations may be accused of violating civil-rights requirements while receiving federal funding or participating in government healthcare programs.
What's changing / Business impact
Hospitals, insurers, pharmaceutical companies, and healthcare providers may face increased scrutiny regarding compliance policies and reporting practices.
Many organizations are expected to review internal procedures to reduce legal risk.
Why this matters
Healthcare organizations receive large amounts of federal funding through programs such as Medicare and Medicaid.
When regulators increase enforcement efforts, companies often need to spend more on compliance, audits, legal reviews, and employee training.